Hypothesis

Hepatic zone 3 hepatocytes accumulate a critical threshold of mtDNA D-loop heteroplasmy that triggers a bistable switch from adaptive lipid oxidation to maladaptive fibrogenesis, and selective elimination of this heteroplasmy reverses NAFLD progression.

Mechanistic Rationale

• The D-loop, lacking histone protection, is a hotspot for oxidative lesions D-loop is particularly susceptible to oxidative damage. Oxidative damage stalls mtDNA replication, promoting deletion mutants and point mutations that increase heteroplasmy.
• In zone 3, low O2 and high fatty‑acid oxidation raise ROS production, exacerbating D-loop damage while hypoxic signaling suppresses mitophagy Impaired mitophagy drives NAFLD progression, allowing mutant genomes to persist.
• Once heteroplasmy exceeds a zone‑specific threshold (≈30% mutant load), transcriptional reprogramming shifts from PPARα‑driven β‑oxidation to TGF‑β‑driven stellate cell activation, producing an abrupt phenotypic transition Progressive heteroplasmy increases cause abrupt transcriptional reprogramming.
• Nuclear‑encoded regulators of mtDNA copy number cannot compensate because the lesion resides in the replication control region Nuclear genome regulates mtDNA copy number and heteroplasmy.

Experimental Design

1. Spatial mapping – Laser‑capture microdissection of zones 1, 2, 3 from human NASH livers and mouse m

Hypothesis

If retinal mitochondrial function determines the responsiveness of intrinsically photosensitive retinal ganglion cells (ipRGCs) to blue light, then boosting mitochondrial health with a targeted antioxidant will increase ipRGC sensitivity to morning blue‑enriched light, producing larger phase advances and improved sleep metrics without exacerbating evening blue‑violet phototoxicity.

Mechanistic Rationale

ipRGCs rely on melanopsin regeneration and calcium signaling, both energy‑intensive processes that depend on healthy mitochondria【https://www.chronobiologyinmedicine.org/m/journal/view.php?number=167】. Retinal mitochondria are vulnerable to oxidative stress, especially from blue‑violet wavelengths (415‑455 nm) that cause photodamage【https://doi.org/10.1038/s41419-018-0331-5】. When mitochondrial efficiency declines, opsin recycling slows, reducing photon capture and weakening melatonin suppression signals to the suprachiasmatic nucleus. Conversely, enhancing mitochondrial resilience should preserve opsin turnover, heighten ipRGC firing, and strengthen circadian entrainment pathways.

Recent work shows that melatonin suppression alone does not predict sleep improvement from evening blue‑blockers【https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1699303/full】, suggesting variability in ipRGC sensitivity drives inconsistent outcomes. Moreover, morning bright blue‑enriched light advances phase, lengthens sleep, and amplifies melatonin rhythms【https://journal.psych.ac.cn/xlkxjz/EN/Y2023/V31/I9/1698】. Linking mitochondrial health to this re

Hypothesis

Aging osteoblasts and osteocytes increase secretion of extracellular vesicles (EVs) enriched in microRNA-29b (miR-29b). These EVs are taken up by neighboring osteoblasts where miR-29b directly represses the gamma-glutamyl carboxylase gene (GGCX) and the transcripts of mineral transport proteins (ALP, ANK, ClC3). Reduced GGCX activity raises serum undercarboxylated osteocalcin (ucOC) while lowered transporter expression impairs calcium and phosphate delivery to the matrix. The resulting imbalance produces two concurrent phenotypes: (1) insufficient carboxylated osteocalcin fails to restrain hydroxyapatite (HA) crystal growth, allowing larger, more brittle crystallites; and (2) localized mineral-transport deficits create pockets of under-mineralized osteoid alongside hyper-mineralized zones. This dual hit explains the heterogeneous mineralization pattern observed in aged bone and why vitamin K supplementation, which only corrects the carboxylation step, does not fully rescue bone quality.

Mechanistic Rationale

• miR-29b is known to target GGCX in hepatocytes and to suppress alkaline phosphatase expression in cancer cells. Although not yet shown in bone, the conserved seed matches in the 3'-UTR of GGCX, ALPP, ANKH, and CLCN3 suggest a coordinated regulatory module.
• Osteocyte lacunar-canalicular network releases EVs in response to oxidative stress and SASP factors; EV miRNA cargo shifts with age.
• Restoring carboxylated osteocalcin normalizes HA nucleation, but without adequate mineral-transport capacity the excess calcium phosphate precipitates abnormall

Hypothesis

Acarbose extends lifespan primarily through a gut‑to‑brain signal: increased colonic short‑chain fatty acids (SCFAs) stimulate vagal afferents, which then activate hypothalamic AMPK‑FOXO pathways to drive systemic longevity mechanisms. This cascade is male‑biased because androgen signaling up‑regulates the SCFA receptor FFAR3 (Gpr41) on vagal neurons, whereas estrogen in females suppresses FFAR3 expression, attenuating the signal despite similar SCFA production and systemic metabolic improvements.

Testable Predictions

• Vagotomy abolishes longevity: Male mice receiving acarbose + subdiaphragmatic vagotomy will show no lifespan extension, while intestinal alpha‑glucosidase inhibition (measured by post‑prandial glucose) remains intact.
• Microbiome depletion blocks effect: Antibiotic‑treated males on acarbose will fail to increase circulating SCFAs and will not exhibit lifespan gain, confirming microbiota dependence.
• FFAR3 loss phenocopies vagotomy: Male FFAR3‑KO mice on acarbose will have normal SCFA levels but lack vagal activation (reduced c‑Fos in nodose ganglion) and show no lifespan extension.
• Estrogen modulation: Ovariectomized females given acarbose will regain male‑like lifespan extension; conversely, testosterone‑treated females will not further increase benefit beyond baseline, indicating hormone‑dependent receptor regulation.
• Hypothalamic AMPK activation is downstream: Pharmacological inhibition of hypothalamic AMPK in males will block acarbose‑induced FOXO nuclear translocation and lifespan extension, despite pre

Hypothesis

Core claim: With advancing age, loss of autophagic flux in hepatocytes triggers a hypoxic‑stress response that elevates hepatic synthesis of coagulation Factor VIII, thereby contributing to the systemic prothrombotic phenotype of aging. Restoring autophagy normalizes HIF‑1α activity and reduces FVIII output.

Mechanistic rationale

• Autophagy normally removes damaged mitochondria, limiting mitochondrial ROS production. When autophagic flux falls (see PMC9835585), ROS accumulate and stabilize HIF‑1α even under normoxia.
• HIF‑1α binds hypoxia‑response elements in the F8 promoter, boosting transcription of Factor VIII mRNA. This links organelle quality control directly to clotting factor synthesis.
• Elevated plasma Factor VIII can activate thrombin generation; thrombin‑PAR1 signaling feeds back to stimulate mTORC1, which further suppresses autophagy (PubMed24853422), creating a vicious cycle.
• Young plasma reverses hepatic autophagy impairment in rats (DOI10.1111/acel.12708), suggesting that systemic factors can restore autophagic capacity and thereby lower HIF‑1α‑driven FVIII expression.
• Bone‑marrow‑derived secretory changes with autophagy loss (Aging-us203127) may amplify inflammation, but the hepatic axis provides a direct route to the coagulation cascade.

Testable predictions

1. Genetic loss – Liver‑specific Atg7 knockout in young mice will recapitulate the

Hypothesis

The epigenetic age of the gut microbiome, not host cellular senescence, initiates the inflammaging cascade that accelerates brain aging; prolonged fasting reverses this by inducing autophagy-dependent remodeling of the microbial epigenome.

Mechanistic Reasoning

• Age‑related shifts in gut microbiota increase production of metabolites such as indole‑propionic acid and secondary bile acids that act as histone deacetylase inhibitors in host cells, leading to NF‑κB activation and microglial priming.
• These microbial metabolites also alter DNA methylation patterns within the microbiome itself, creating a measurable “microbiome epigenetic clock” that predicts host systemic inflammation better than host telomere length.
• Fasting triggers neuronal autophagy via mTOR inhibition and AMPK/SIRT1 activation, which concurrently upregulates gut epithelial autophagy, enhancing barrier function and reducing metabolite leakage.
• Importantly, autophagy in intestinal epithelial cells promotes turnover of mucus‑associated microbes, allowing recolonization by youth‑associated taxa whose epigenetic state is reset through reduced exposure to host‑derived oxidative stress, thereby lowering the microbiome epigenetic age.

Testable Predictions

1. In cross‑sectional human cohorts, the microbiome epigenetic age (derived from methyl‑seq of stool DNA) will correlate positively with plasma IL‑6, TNF‑α, and CSF p‑tau, independent of host age.
2. Participants undergoing a 4‑week intermittent fasting regimen will show a significant reduction in microbiome epigenetic age alongside decr

Chronic sleep loss impairs the brain’s nightly verdict on which synaptic configurations survive. The glymphatic system performs an active triage during sleep, tagging extracellular waste for removal while sparing functional networks. Simultaneously, intracellular autophagy degrades damaged proteins and organelles. Both pathways peak during rest, yet most interventions treat them as independent. Crocetin, a carotenoid from saffron, robustly activates the STK11/LKB1‑AMPK axis, driving ATG5/7/12 expression and LC3B‑II flux in neurons【https://pmc.ncbi.nlm.nih.gov/articles/PMC8632093/】. Its pharmacokinetic profile shows brain Tmax at ~1 h and a half‑life of ~3.1 h after oral dosing【https://pmc.ncbi.nlm.nih.gov/articles/PMC8632093/】, aligning neatly with the early‑sleep window when aquaporin‑4 polarization surges and CSF influx accelerates【https://gethealthspan.com/science/article/glymphatic-system-autophagy-neurodegenerative-disease-prevention】.

We hypothesize that administering crocetin 30 minutes before bedtime couples autophagy induction with glymphatic flow, converting the two clearance mechanisms into a coordinated detoxification surge. In this coupled state, autophagosomes engulf intracellular Aβ oligomers and phosphorylated tau fragments, while the glymphatic conduit simultaneously clears extracellular plaques and soluble oligomers that have been shed from membranes. The temporal overlap should reduce the total burden of toxic species more effectively than either pathway alone, thereby improving the fidelity of synaptic triage.

Testable predictions: (1) Mice receivi

Hypothesis

Aging-related decline in colonic motility stems not only from reduced SCFA‑driven TPH1 expression in enterochromaffin (EC) cells but also from altered bile acid sensing that converges on the same serotonergic output pathway. Restoring both microbial SCFA signaling and bile acid receptor activity will rescue EC‑cell serotonin release and improve propulsive motility more effectively than either intervention alone.

Mechanistic Basis

• EC cells express the G‑protein‑coupled receptor TGR5, which is activated by secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) (source).
• TGR5 activation raises intracellular cAMP, potentiating Ca²⁺‑dependent vesicle exocytosis and thus amplifying serotonin release downstream of TPH1 (source).
• Age‑associated microbiome shifts diminish butyrate‑producing taxa and concurrently increase bile‑acid 7‑α‑dehydroxylating bacteria, elevating luminal DCA/LCA while butyrate falls (source).
• We propose that EC cells act as coincidence detectors: optimal serotonin output requires both sufficient SCFA‑mediated TPH1 transcription (providing substrate) and bile‑acid‑driven TGR5 signaling (providing secretory potency). Loss of either input reduces serotonin release; loss of both produces the severe motility deficits observed in aged colons.

Testable Predictions

1. In vitro: Human EC‑cell lines treated with physiological butyrate (1 mM) plus physiolog

Hypothesis

Acetate supplementation drives ACSS2 nuclear translocation in hypothalamic microglia, generating a localized acetyl-CoA pool that selectively acetylates histones at anti‑inflammatory gene promoters (e.g., "Il10", "Tgfb1") and deacetylates pro‑inflammatory loci ("Nlrp3", "Casp1") through a SIRT1‑ACSS2 antagonistic complex, thereby suppressing microglial inflammasome activation and breaking the mitochondrial‑epigenetic vicious cycle of aging.

Mechanistic Model

1. Acetate uptake via monocarboxylate transporters (MCT1/2) raises cytosolic acetate.
2. ACSS2 is acetylated at lysine residues by acetyl‑CoA synthetase activity, exposing a cryptic nuclear localization signal (NLS) that promotes importin‑α/β binding.
3. In the nucleus, ACSS2 forms a transient complex with SIRT1; the acetyl‑CoA produced by ACSS2 allosterically inhibits SIRT1’s deacetylase activity, shifting the local equilibrium toward histone acetylation.
4. This acetyl‑CoA/SIRT1 module preferentially targets enhancers of TFEB‑dependent lysosomal genes and promoters of anti‑inflammatory cytokines, increasing H3K27ac and H3K9ac.
5. Concomitantly, the same complex recruits the HDAC3‑NCoR repressor to NF‑κB‑bound promoters, facilitating deacetylation and transcriptional repression of inflammasome components.
6. The net effect is enhanced lysosomal biogenesis, improved mitophagy, and reduced NLRP3 inflammasome‑driven IL‑1β release.

Predictions

• Acetate treatment will increase nuclear ACSS2 signal (immunofluorescence) and H3K27ac at "Il10" and "Tgfb1" promoters in microglia f

Hypothesis

Senescent cells function as tunable signaling hubs whose acetyl‑CoA‑dependent histone acetylation acts as a metabolic rheostat that selectively sculpts the SASP. We propose that boosting nuclear acetyl‑CoA via acetate supplementation reprograms the SASP from a predominantly pro‑inflammatory, immune‑attracting profile to a pro‑repair, immunomodulatory secretome. This shift would alter the "hostage negotiator" output: instead of signaling for their own removal, senescent cells would promote stromal regeneration and limit fibrosis, thereby changing the trade‑off between clearance and tissue homeostasis.

Mechanistic Rationale

1. Acetyl‑CoA compartmentalization controls histone acetylation at SASP loci – Nuclear acetyl‑CoA generated by ACSS2 from acetate directly fuels HATs, maintaining open chromatin at specific SASP promoters (PMC8068152).
2. Differential sensitivity of SASP components to acetylation – HDAC1 inhibition preferentially up‑regulates factors such as osteopontin, indicating that individual SASP genes have distinct acetylation thresholds (PMC5748661).
3. Metabolic stress biases SASP composition – During aging, reduced NAD+/NADH and pyruvate dehydrogenase activity lower acetyl‑CoA, favoring a SASP rich in IL‑6, IL‑8, and MMPs that attract immune cells (PMC8068152). Acetate supplementation can bypass this defect, restoring nuclear acetyl‑CoA without relying on glycolytic flux.

Hypothesis

Extreme cold‑water immersion at 1 °C (34 °F) can override age‑related Ink4a/Arf‑mediated senescence in adipocyte progenitors, triggering beige adipocyte formation via a norepinephrine‑driven β3‑adrenergic/cAMP/PKA pathway.

Mechanistic rationale

• Repeated bouts of supra‑physiologic cold elicit norepinephrine spikes >800 % (extrapolating from the 530 % rise seen at 10‑15 °C)【Cold‑water Immersion: Neurohormesis and Possible Therapeutic】.
• Massive β3‑adrenergic receptor activation raises intracellular cAMP, activating PKA, which phosphorylates CREB and induces PGC‑1α transcription.
• PKA‑dependent signaling also suppresses the Ink4a/Arf locus through HDAC‑mediated chromatin remodeling, a mechanism shown in senescent cell reversal models【Cellular aging contributes to failure of cold‑induced beige adipocyte formation in old mice and humans】.
• The resulting decline in senescence markers permits progenitor cells to differentiate into beige adipocytes, increasing UCP1‑mediated thermogenesis and mitochondrial biogenesis.
• This epigenetic shift is reminiscent of the reprogramming observed in induced pluripotent stem cells, where cAMP/PKA signaling drives a permissive chromatin state.

Testable predictions

We don't expect the effect to appear without the extreme stimulus, so we predict:

1. In a crossover study, adults >60 y undergoing six daily 3‑min immersions at 1 °C will show a ≥2‑fold increase in circulating norepinephrine vs baseline (measured by ELISA)【Effects of cold‑water immersion on health and wellbeing】.
2. Biopsies of subcutaneous adipose tissue afte

Background

Smartphone usage generates continuous, passively collected behavioral data that may encode subclinical musculoskeletal changes invisible to periodic clinical assessments. In rheumatoid arthritis (RA), metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joint inflammation produces measurable biomechanical alterations — increased joint stiffness, reduced grip strength, and impaired fine motor coordination — that precede patient-reported symptoms and composite disease activity index elevation.

Hypothesis

Passively collected smartphone keystroke dynamics — including inter-key interval variability, touch contact area, touch pressure distribution asymmetry between hands, and typing error rate — undergo statistically detectable shifts 4–10 weeks before DAS28 flare criteria are met in RA patients. Specifically:

1. Inter-key interval coefficient of variation (CV) increases by >15% from individual baseline during subclinical inflammation, reflecting impaired fine motor planning in inflamed MCP/PIP joints
2. Touch pressure asymmetry index (dominant vs non-dominant hand) diverges significantly (Cohen d > 0.5) when unilateral synovitis develops, as the affected hand compensates with altered force distribution
3. Typing error burst frequency (≥3 consecutive corrections within 2 seconds) increases >2-fold, reflecting proprioceptive disruption from periarticular edema
4. A random forest classifier combining these features with circadian typing pattern entropy achieves >80% sensitivity and >75% specificity for predicting clinical flare 4–10 weeks in

Evening exposure to blue‑rich light (460‑480 nm) suppresses melatonin via ipRGCs, shifting circadian phase and increasing oxidative stress【https://www.chronobiologyinmedicine.org/m/journal/view.php?number=167】. We hypothesize that this light‑induced melatonin drop also reduces gut‑derived short‑chain fatty acid (SCFA) production, weakening SCFA signaling to peripheral clocks and accelerating aging phenotypes. Specifically, blue light‑mediated circadian disruption lowers colonic fermentation of fiber, decreasing acetate, propionate and butyrate that normally entrain liver, muscle and adipose clocks through GPR41/43 activation and HDAC inhibition【https://pmc.ncbi.nlm.nih.gov/articles/PMC12996223】. The resulting desynchrony between central and peripheral oscillators amplifies inflammatory NF‑κB signaling and mitochondrial ROS, driving the aging cascade linked to cardiovascular disease, insulin resistance and cognitive decline【https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2025.1646794/full】. Thus, evening blue light acts as a dual hit: directly dampening melatonin and indirectly eroding the gut‑brain‑clock axis, together hastening biological aging.

Mechanism

1. Blue light activates ipRGCs → ↓ melatonin secretion → ↓ MT1/MT2 receptor signaling in enterochromaffin cells.
2. Reduced melatonin diminishes ileal motility and mucus secretion, slowing transit time and altering substrate availability for saccharolytic bacteria.
3. Microbiota shift toward proteolytic taxa, lowering SCFA yields (acetate, propionate, butyrate) as shown in fiber‑feeding studies【https

Hypothesis

Progressive loosening of the inactive X chromosome (Xi) in aging females increases the dosage of X-linked immune genes (e.g., TLR7, TLR8, IRAK1), driving chronic JAK-STAT activation. Rather than simply exhausting the pathway, this sustained stimulus triggers a compensatory epigenetic program that reinforces negative feedback regulators (SOCS1/3, PIAS1, PTPN2) at the same X-linked loci, creating a bistable switch: low interferon sensitivity in youth, high sensitivity during mid‑life Xi escape, and refractory insensitivity in late age. The switch is mediated by XIST‑dependent recruitment of HDAC3 and DNMT3A to promoter regions of feedback genes, which becomes destabilized as Xi escape spreads.

Mechanistic Reasoning

1. Dosage‑Dependent Feedback Induction – X‑linked immune genes and their corresponding feedback inhibitors are co‑located in topologically associating domains (TADs) that retain Xi‑specific chromatin contacts. When immune gene transcription rises due to Xi escape, enhancer‑promoter looping also brings feedback gene promoters into proximity with active RNA polymerase II, facilitating their transcription.
2. Epigenetic Buffering – In young females, XIST RNA coats Xi and recruits HDAC3/DNMT3A, keeping feedback genes poised but silent. Chronic IFN signaling activates STAT1, which phosphorylates HDAC3, reducing its affinity for chromatin and allowing transient feedback expression. With age, Xi erosion diminishes XIST spread, weakening HDAC3/DNMT3A recruitment and causing feedback genes to become constitutively expressed, thereby dampening JAK

Hypothesis

Elevated carotid‑femoral pulse wave velocity (cfPWV) reflects increased arterial stiffness that transmits heightened pulsatile stress to the microvasculature of the gut wall. This mechanotransduction activates endothelial Piezo1 channels, driving local superoxide production and reducing nitric oxide (NO) bioavailability in intestinal endothelial cells. The resulting gut endothelial dysfunction increases permeability, allowing bacterial translocation and endotoxin influx, which fuels systemic inflammation (SASP amplification) and worsens endothelial NO uncoupling in the vasculature. Consequently, the gut‑vascular axis creates a self‑reinforcing loop that accelerates frailty through impaired muscle perfusion and cognitive decline via heightened neuroinflammation.

Mechanistic Rationale

• Piezo1‑dependent NO scavenging: Stretch‑activated Piezo1 channels, known to be upregulated in aged endothelium, convert mechanical strain into Ca2+ influx that stimulates NADPH oxidase (NOX2) and superoxide generation, scavenging NO (source).
• Gut barrier breach: Superoxide‑mediated nitrosylation of tight‑ junction proteins (occludin, claudin‑5) increases paracellular flux, measurable by plasma zonulin or LPS‑binding protein (source).
• Inflammatory amplification: Circulating LPS engages TLR4 on endothelial and senescent cells, boosting IL‑6, IL-1β and SASP factors, which further suppress eNOS activity and promote ADMA accumulation ([source](https:

Hypothesis\nSleep does not merely permit autophagy; it triggers a two‑step molecular switch that couples the circadian clock to lysosomal readiness. During wakefulness, inflammatory signaling maintains BCL‑2 phosphorylated at Ser70, which locks Beclin‑1 in an inactive complex. Sleep onset drives a rapid dephosphorylation of BCL‑2 Ser70 via protein phosphatase 2A (PP2A), releasing Beclin‑1 to initiate autophagosome formation. Simultaneously, the rise in extracellular adenosine during sleep inhibits mTORC1, allowing V‑ATPase assembly on lysosomes and acidification. Only when both events coincide—BCL‑2 dephosphorylation and mTORC1 suppression—does the cell execute autophagic triage, degrading selectively damaged proteins and organelles. Aging or chronic sleep loss sustains BCL‑2 Ser70 phosphorylation and blunts adenosine accumulation, uncoupling Beclin‑1 release from lysosomal activation and yielding a pool of idle autophagosomes that cannot mature, thus explaining the observed increase in Beclin‑1 protein without flux.\n\n## Mechanistic Model\n1. Circadian input – Core clock component BMAL1 drives nightly expression of PP2A regulatory subunits, peaking in NREM sleep.\n2. Sleep‑dependent metabolite – Adenosine accumulates as neuronal firing declines, binding A1 receptors to inhibit adenylyl cyclase, lowering cAMP and reducing PKA‑mediated mTORC1 activity.\n3. BCL‑2 regulation – PP2A dephosphorylates BCL‑2 at Ser70, decreasing its affinity for Beclin‑1; phosphorylated BCL‑2 retains high affinity and blocks autophagy.\n4. Lysosomal priming – Low mTORC1 permits

Hypothesis

Restoring mitochondrial coenzyme Q10 (CoQ10) biosynthesis specifically in pericentral (zone 3) hepatocytes will prevent ferroptosis‑driven progression of metabolic dysfunction‑associated steatotic liver disease (MASLD) in aging, independent of systemic iron overload.

Rationale

• Aging hepatocytes show a preferential loss of zonation markers (Ctnnb1, Foxo1, Tcf7l2) and an expansion of aberrant bi‑zonal cells that co‑express ASS1, CYP2E1 and GS [1].
• Zone 3 cells in aged MASLD livers accumulate lipids, undergo lipid peroxidation and display a ferroptotic‑senescent hybrid state termed ferrosenescence [2].
• Recent snRNA‑seq data reveal that the Aging Hepatocyte Gene Signature (AHGS) captures this ferrosenescent population and predicts advanced fibrosis with AUC > 0.80 [2].
• Mitochondrial dysfunction is an upstream driver of ferroptosis; reduced CoQ10 compromises electron transport, elevates superoxide, and fuels phospholipid peroxidation [3].
• In young livers, Wnt/β‑catenin signaling sustains COQ2 expression in zone 3; aging‑associated β‑catenin decline therefore predicts a zone‑specific CoQ10 deficit.

Novel Mechanistic Insight

We propose that the age‑dependent drop in Wnt/β‑catenin activity directly suppresses COQ2 transcription in pericentral hepatocytes, creating a localized bottleneck in ubiquinone synthesis. This mitochondrial CoQ10 shorta

Hypothesis

Continuous mTOR inhibition mimics a permanent scarcity signal, eliciting stress‑adaptation pathways without triggering the anabolic phases needed for macromolecular repair. We propose that delivering rapamycin in intermittent bursts aligned with the endogenous circadian trough of hepatic mTOR activity will restore rhythmic cycles of catabolism and anabolism, thereby enabling true rejuvenation—measured by epigenetic age reversal, improved proteostasis, and restored proliferative capacity—while retaining the lifespan‑extending benefits of autophagy induction.

Mechanistic Rationale

• mTORC1 activity naturally oscillates over the 24‑h cycle, peaking during the active phase and declining during rest [[https://pmc.ncbi.nlm.nih.gov/articles/PMC6075448/]]. This rhythmic suppression coincides with heightened autophagy and reduced protein synthesis [[https://www.jci.org/articles/view/64099]].
• Constant rapamycin exposure flattens this rhythm, creating a chronic “hardship” state that upregulates stress defenses (e.g., inflammation reduction, stem‑cell niche support) but does not activate repair programs that require transient mTORC1 re‑engagement, such as translation‑fidelity checkpoint activation or NAD^+‑dependent sirtuin activity.
• Brief periods of mTORC1 reactivation (e.g., during the circadian peak) can restore ribosome biogenesis and chaperone‑mediated folding, allowing cells to clear accumulated misfolded proteins and reset epigenetic marks via increased acetyl‑CoA production.
• Importantly, intermittent inhibition preserves autophagy induction because each

Hypothesis

Hormetic stressors such as intermittent fasting, mild heat shock, or exercise extend lifespan by engaging the replication‑stress response machinery, not by altering histone methylation states. KDM5A/B are recruited to stalled replication forks where they act as scaffolds for CHK1 activation and RRM2 upregulation, a role that does not require their demethylase activity [PMC8181900]. Consequently, the longevity benefit of hormesis should persist when the catalytic domain of KDM5 is inactivated but disappear when the protein is depleted or its protein‑protein interaction surfaces are disrupted.

Testable Predictions

1. Catalytic‑dead rescue – In C. elegans or mouse models expressing a demethylase‑deficient KDM5A/B point mutant (e.g., H604A/H606A in the JmjC domain) on a background of endogenous KDM5 loss, hormetic interventions (e.g., every‑other‑day fasting or voluntary wheel running) will still increase median lifespan compared with wild‑type controls.
2. Scaffold disruption abolishes hormesis – Introducing mutations that prevent KDM5 interaction with CHK1 or RRM2 (identified from structural studies) will block the lifespan extension normally seen with hormesis, even though global H3K4me3 levels remain unchanged.
3. Epigenetic read‑out is dispensable – Chromatin immunoprecipitation sequencing after a hormetic pulse will show no significant change in H3K4me3/H3K27me3 at bivalent promoters in tissues derived from catalytic‑dead animals, yet downstream signaling (phospho‑CHK1, increased dN

Background

A critical treatment gap exists in SLE management: hydroxychloroquine (~$6/month) serves as the universal backbone therapy, but the next escalation step jumps to expensive biologics (belimumab, anifrolumab) costing thousands per month — largely inaccessible in low- and middle-income countries. An affordable intermediate option targeting the underlying metabolic dysfunction in lupus T-cells is urgently needed.

Hypothesis

In SLE patients with incomplete disease control on hydroxychloroquine, adding low-dose sirolimus (1–2 mg/day) plus metformin (500–1000 mg/day) will achieve superior restoration of T-cell metabolic homeostasis — measured by normalization of mitochondrial membrane potential and reversal of the Th17/Treg ratio — compared to hydroxychloroquine monotherapy alone.

Mechanistic Rationale

Lupus T-cells exhibit constitutive mTORC1 hyperactivation, driving HRES-1/Rab4 GTPase overexpression, TCRζ chain loss, and enhanced calcium signalling. Sirolimus directly reverses mTOR hyperactivity and normalizes downstream S6K1/4E-BP1 phosphorylation in lupus T-cells. Metformin inhibits mitochondrial complex I, activates AMPK, and suppresses mTOR through a complementary pathway — creating convergent metabolic reprogramming. Proof-of-concept from oncology shows that sirolimus + metformin combination in CAR-T cells induces AMPK activation, PGC-1α induction, and enhanced mitochondrial spare respiratory capacity, suggesting synergistic effects translatable to lupus T-cell biology.

Novelty

No clinical trial has tested the triple combination. A Phase 1 stud